Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation-Reference-Cited by-同舟云学术

Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation

Published:2005-03 Issue:3 Volume:16 Page:337-344
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:Anti-Cancer Drugs

Author:

Oechtering Doris,Schiltmeyer Brunhild,Hempel Georg,Schwab Matthias,W??rthwein Gudrun,M??rdter Thomas,Klingebiel Thomas,Vormoor Josef,Gruhn Bernd,Fleischack Gudrun,Boos Joachim

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference34 articles.

1. Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease.

2. Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

3. Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alkylpyridines and Miscellaneous Organic Nitrogen Compounds;Patty's Toxicology;2023-12-19

2. Pulmonary hypertension associated with busulfan;Pulmonary Circulation;2021-09

3. Predictive Performance of a Physiologically Based Pharmacokinetic Model of Busulfan in Children;Pediatric Hematology and Oncology;2014-07-09

4. Association Between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation;Therapeutic Drug Monitoring;2014-02

5. Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients;Pediatric Blood & Cancer;2013-10-30